viral
lower
airway
infect
common
infant
preschool
children
sever
respiratori
symptom
vari
mild
cough
congest
respiratori
failur
requir
endotrach
intub
mechan
ventil
predict
children
recov
quickli
versu
progress
sever
ard
ardsspecif
pharmacolog
treatment
exist
rather
treatment
support
use
lungprotect
ventil
strategi
administr
antibiot
suspect
bacteri
infect
studi
immun
regul
children
need
lung
immun
matur
critic
stage
develop
primari
caus
pard
direct
lung
injuri
due
ard
character
refractori
hypoxemia
noncardiogen
pulmonari
edema
due
damag
lung
epithelium
pulmonari
endothelium
adult
ard
increas
count
airway
neutrophil
associ
sever
lung
injuri
airway
neutrophil
adult
ard
enhanc
surviv
prime
respiratori
burst
respons
increas
phagocyt
patient
pulmonari
diseas
character
chronic
bacteri
infect
cystic
fibrosi
airway
neutrophil
inhibit
tcell
function
via
two
pathway
deplet
arginin
follow
degranul
activ
activ
program
death
program
axi
result
reduc
prolifer
impair
effector
contrast
pulmonari
environment
influenc
immun
cell
regul
poorli
character
pard
due
lack
model
system
abl
recapitul
airway
neutrophil
phenotyp
sever
paediatr
lung
injuri
clinic
inform
obtain
bedsid
often
use
prognost
yet
insuffici
determin
pathobiolog
lung
injuri
understand
biolog
neutrophil
recruit
lung
pard
crucial
advanc
prognost
risk
stratif
develop
novel
therapeut
strategi
children
progress
sever
pard
herein
hypothes
marker
degranul
surfac
airway
neutrophil
cellfre
airway
fluid
within
intub
would
associ
bacteri
respiratori
coinfect
use
vitro
model
base
blood
neutrophil
transepitheli
migrat
airway
fluid
endotrach
intub
children
suspect
confirm
lower
airway
viral
infect
risk
progress
hypothes
neutrophil
recruit
cellfre
airway
fluid
children
bacteri
coinfect
would
defect
respiratori
burst
abil
kill
bacteria
compar
children
bacteri
coinfect
prospect
observ
studi
perform
paediatr
intens
care
unit
picu
children
healthcar
atlanta
egleston
januari
april
studi
approv
institut
review
board
emori
univers
confirm
research
perform
accord
relev
guidelin
regul
inform
consent
obtain
parent
subject
prior
collect
use
sampl
patient
greater
hour
age
correct
gestat
age
least
week
year
old
younger
admit
picu
met
criteria
risk
pard
defin
pediatr
acut
lung
injuri
consensu
confer
palicc
screen
elig
enrol
studi
children
lung
injuri
within
day
known
clinic
insult
new
infiltr
consist
acut
pulmonari
parenchym
diseas
chest
imag
receiv
oxygen
deliv
either
noninvas
invas
maintain
oxygen
satur
rang
respiratori
viral
infect
confirm
respiratori
viral
polymeras
chain
reaction
test
order
discret
primari
medic
team
care
patient
although
viral
infect
may
suspect
patient
clinic
identif
viru
laboratori
test
children
exclud
perinat
relat
lung
diseas
respiratori
failur
fulli
explain
cardiac
failur
fluid
overload
chronic
respiratori
failur
mechan
ventil
via
tracheostomi
ram
cannula
confirm
immunodefici
disord
immunosuppress
chemotherapi
oncolog
process
chronic
immunosuppress
bone
marrow
transplant
solid
organ
transplant
recipi
parent
legal
guardian
present
provid
written
inform
consent
attend
physician
wish
patient
particip
studi
clinic
data
abstract
medic
record
onto
standard
form
variabl
includ
demograph
fraction
inspir
oxygen
mean
airway
pressur
arteri
oxygen
satur
arteri
oxygen
pressur
use
calcul
oxygen
satur
index
osi
oxygen
index
oi
respect
laboratori
microbiolog
result
length
mechan
ventil
need
reintub
length
picu
stay
use
high
frequenc
oscillatori
ventil
hfov
extracorpor
membran
oxygen
ecmo
vital
statu
sever
ill
determin
pediatr
risk
mortal
prism
iii
pediatr
logist
organ
dysfunct
pelod
score
calcul
within
hour
picu
need
mechan
ventil
monitor
calcul
ventilatorfre
lung
injuri
sever
categor
accord
palicc
follow
risk
oi
osi
mild
oi
osi
moder
oi
osi
sever
oi
osi
ml
blood
specimen
collect
kedta
vacutain
becton
dickinson
franklin
lake
nj
within
hour
endotrach
intub
children
weigh
greater
kg
either
arteri
central
venou
cathet
serial
blood
sampl
collect
everi
day
one
week
weekli
thereaft
durat
mechan
ventil
andor
presenc
either
arteri
central
venou
cathet
assay
neutrophil
activ
perform
within
hour
blood
collect
cell
kept
assay
perform
tracheal
aspir
obtain
patient
convent
mechan
ventil
instil
ml
steril
salin
inlin
ballard
suction
cathet
steril
luken
trap
part
routin
suction
serial
tracheal
aspir
sampl
collect
everi
day
one
week
weekli
thereaft
durat
mechan
ventil
weight
limit
tracheal
aspir
could
obtain
patient
children
mechan
ventil
high
frequenc
oscil
ventil
suction
clinic
indic
approv
attend
physician
tracheal
aspir
sampl
immedi
place
ice
transport
laboratori
process
blood
spun
g
separ
cell
plateletrich
plasma
plasma
spun
g
gener
plateletfre
plasma
aliquot
store
pellet
blood
cell
resuspend
phosphat
buffer
salin
pb
mm
ethylenediaminetetraacet
acid
edta
origin
whole
blood
volum
flow
cytometri
analysi
neutrophil
purif
neutrophil
purifi
neg
select
pbsedtawash
whole
blood
use
easysep
direct
human
neutrophil
isol
kit
stemcel
technolog
inc
cambridg
accord
manufactur
instruct
tracheal
aspir
gentli
dissoci
use
repeat
passag
g
needl
addit
ml
pbsedta
dissoci
tracheal
aspir
centrifug
g
gener
cell
pellet
fluid
fraction
fluid
fraction
spun
g
gener
cellfre
airway
supernat
asn
aliquot
store
airway
cell
resuspend
pbsedta
count
use
countess
cytomet
use
flow
cytometri
assay
use
vitro
model
recent
develop
group
recapitul
airway
neutrophil
phenotyp
chosen
patholog
lung
environ
model
previous
appli
cystic
fibrosi
cf
asthma
chronic
obstruct
pulmonari
diseas
copd
use
asn
patient
condit
ad
apic
attract
condit
naiv
blood
neutrophil
small
airway
epitheli
line
briefli
purifi
blood
neutrophil
load
onto
basal
compart
alvetex
scaffold
reprocel
glasgow
uk
coat
collagen
monolay
cell
human
club
cell
line
grown
two
week
airliquid
neutrophil
allow
migrat
hour
collagen
epitheli
layer
apic
compart
compris
asn
dilut
rpmi
medium
lglutamin
medium
chemoattract
leukotrien
nm
blood
airway
neutrophil
collect
patient
vivo
neutrophil
transmigr
vitro
model
preincub
human
trustain
fcx
receptor
block
solut
biolegend
san
diego
ca
livedead
aqua
thermo
fisher
scientif
waltham
min
ice
dark
follow
label
antibodi
list
tabl
min
panel
appli
blood
sampl
due
limit
number
cell
tracheal
aspir
sampl
flow
cytometri
panel
detail
tabl
priorit
follow
panel
airway
puriti
fluoresc
minu
control
panel
panel
sampl
treat
bd
lysefix
buffer
bd
bioscienc
san
jose
ca
wash
twice
pbsedta
store
dark
acquisit
cytoflex
flow
cytomet
beckman
coulter
indianapoli
transmigr
neutrophil
similarli
stain
flow
panel
describ
tabl
acquir
lsrii
cytomet
bd
bioscienc
compens
use
abc
total
antibodi
arc
aminereact
compens
bead
thermo
fisher
scientif
gate
analysi
perform
flowjo
tree
star
ashland
singl
cell
separ
doublet
cell
gate
forward
scatter
area
versu
forward
scatter
height
neutrophil
select
base
forward
scatter
area
versu
side
scatter
area
profil
live
cell
select
exclus
dead
event
posit
dye
livedead
aqua
platelet
plateletleukocyt
aggreg
exclud
stain
event
neutrophil
confirm
gate
versu
side
scatter
area
tracheal
aspir
fig
whole
blood
neutrophil
fig
mean
fluoresc
intens
surfac
marker
report
neutrophil
determin
background
mean
fluoresc
intens
signal
five
report
channel
pe
apc
report
mean
fluoresc
signal
intens
neutrophil
blood
airway
sampl
stain
livedead
aqua
fluoresc
minu
fm
five
control
fig
human
neutrophil
elastas
hne
activ
measur
asn
plasma
accord
supplier
protocol
cayman
chemic
ann
arbor
mi
kitsuppli
standard
curv
addit
human
matrix
duoset
myeloperoxidas
mpo
quantikin
elisa
kit
r
system
minneapoli
mn
human
lactoferrin
elisa
kit
abcam
cambridg
use
accord
supplier
protocol
protein
concentr
calcul
use
suppli
standard
curv
data
collect
biotek
winooski
vt
synergi
ht
plate
reader
recommend
wavelength
standard
curv
fit
procedur
neutrophil
respiratori
burst
intens
assess
dihydrorhodamin
stimul
ngml
nformylmethionylleucylphenylalanin
fmlf
describ
use
facscalibur
phorbol
pma
use
final
concentr
nm
posit
control
activ
aureu
h
influenza
grown
luria
broth
lb
chocol
media
respect
aerat
optic
densiti
nm
bacteria
pellet
centrifug
g
min
room
temperatur
resuspend
human
serum
rpmi
opson
min
opson
bacteria
ad
neutrophil
multipl
infect
h
incub
cultur
lyse
use
triton
min
bacteria
serial
dilut
plate
triplic
lb
chocol
agar
plate
respect
overnight
incub
viabl
bacteri
coloni
form
unit
cfu
count
follow
day
report
percentag
bacteri
count
record
bacteria
incub
absenc
neutrophil
statist
perform
use
jmp
pro
sa
institut
cari
nc
prism
graphpad
san
diego
ca
window
unless
otherwis
state
comparison
sampl
made
use
mannwhitney
u
test
anova
posthoc
tukey
test
multipl
comparison
statist
signific
defin
p
valu
less
use
flow
cytometri
compar
express
critic
surfac
marker
blood
airway
neutrophil
children
acut
lower
airway
infect
within
hour
endotrach
intub
repres
flow
cytometri
histogram
show
heterogen
surfac
marker
express
airway
blood
neutrophil
shown
fig
lselectin
low
affin
fc
gamma
receptor
immunoglobulin
g
igg
mediat
degranul
phagocytosi
oxid
burst
shed
upon
airway
migrat
cell
surfac
express
marker
primari
granul
exocytosi
marker
secondari
granul
exocytosi
increas
airway
compar
blood
neutrophil
granul
releas
airway
neutrophil
confirm
presenc
signific
activ
human
neutrophil
elastas
hne
proteas
contain
within
primari
granul
matrix
metalloprotein
protein
level
proteas
contain
within
secretori
granul
cellfre
airway
fluid
compar
plateletfre
plasma
fig
f
character
differ
surfac
express
integrin
respons
adhes
activ
neutrophil
respiratori
burst
complementantigen
present
chemotaxi
receptor
airway
vs
blood
neutrophil
fig
integrin
alpha
integrin
alpha
x
increas
decreas
airway
compar
blood
neutrophil
antigen
present
receptor
hladr
major
histocompat
class
ii
also
increas
airway
compar
blood
neutrophil
complement
receptor
decreas
airway
compar
blood
neutrophil
complement
receptor
medium
affin
igg
receptor
mediat
phagocytosi
oxid
burst
platelet
aggreg
immunomodul
unchang
final
receptor
decreas
airway
neutrophil
compar
blood
neutrophil
neutrophil
degranul
associ
increas
sever
lung
diseas
due
infect
hne
activ
increas
versu
without
airway
bacteri
coinfect
fig
addit
activ
hne
fig
mpo
level
neither
lactoferrin
higher
asn
children
bacteri
coinfect
airway
without
fig
order
character
differ
neutrophil
recruit
airway
children
without
bacteri
coinfect
follow
lower
airway
viral
infect
use
asn
children
lower
airway
viral
infect
collect
within
hour
endotrach
intub
show
patholog
milieu
induc
transepitheli
migrat
blood
neutrophil
vitro
model
similar
modul
observ
primari
airway
neutrophil
patient
donor
neutrophil
transmigr
patient
asn
compar
blood
neutrophil
pretransmigr
fig
although
patient
asn
intrins
hne
activ
evid
surfac
recaptur
hne
transmigr
neutrophil
fig
unlik
vivo
patient
data
complement
receptor
decreas
neutrophil
transmigr
asn
fig
hladr
differ
neutrophil
transmigr
asn
fig
compar
blood
neutrophil
vivo
surfac
marker
express
human
neutrophil
play
role
tissu
upon
neutrophil
transmigr
vitro
upregul
compar
blood
neutrophil
fig
explor
axi
demonstr
express
increas
cell
surfac
neutrophil
transmigr
asn
fig
neutrophil
transmigr
pool
day
asn
patient
decreas
surfac
express
compar
blood
neutrophil
fig
howev
detect
signific
differ
express
blood
airway
neutrophil
vivo
data
shown
experiment
control
use
neg
select
neutrophil
rather
whole
blood
neutrophil
fig
direct
incub
neutrophil
asn
compar
transmigr
fig
show
significantli
differ
result
compar
shown
fig
except
decreas
coincub
experi
compar
transmigr
neutrophil
next
compar
respiratori
burst
capac
blood
neutrophil
fig
neutrophil
transmigr
toward
chemoattract
control
patient
asn
fig
blood
neutrophil
respons
rest
upon
fmlf
stimulu
without
initi
prime
granulocyt
macrophagecoloni
stimul
factor
gmcsf
burst
intens
upon
gmcsf
fmlf
treatment
much
lower
seen
pma
posit
control
fig
contrast
neutrophil
transmigr
toward
pool
day
asn
patient
show
increas
respiratori
burst
intens
fmlf
compar
unstimul
transmigr
neutrophil
fig
coincub
neutrophil
pool
day
asn
without
transmigr
durat
serumfre
media
result
stimul
respiratori
burst
increas
intens
addit
fmlf
neutrophil
transmigr
toward
asn
bimod
diminish
fmlfstimul
respiratori
burst
compar
neutrophil
transmigr
toward
transmigr
small
airway
epitheli
model
prime
neutrophil
increas
respiratori
burst
fmlf
stimul
similar
intens
pma
stimulu
compar
blood
neutrophil
stimul
gmcsf
compar
fig
b
next
compar
neutrophil
transmigr
patient
asn
bacteri
coinfect
correspond
high
hne
activ
transmigr
patient
asn
bacteri
coinfect
correspond
low
hne
activ
shown
fig
neutrophil
transmigr
asn
patient
bacteri
coinfect
lower
fmlfstimul
respiratori
burst
compar
transmigr
asn
patient
without
bacteri
coinfect
neutrophil
transmigr
asn
patient
without
bacteri
coinfect
lower
respiratori
burst
transmigr
condit
led
similar
respiratori
burst
respons
pma
solid
histogram
fig
seen
healthi
donor
blood
neutrophil
circul
neutrophil
patient
also
low
level
prime
shown
low
respiratori
burst
fmlf
stimul
compar
pma
rang
respiratori
burst
intens
rest
fmlf
pma
stimul
illustr
fig
patient
demonstr
blood
neutrophil
prime
respond
fmlf
fig
surfac
express
measur
neutrophil
patient
blood
obtain
within
hour
intub
rest
follow
stimul
fmlf
pma
neutrophil
shed
high
express
previous
associ
immunosuppress
phenotyp
neutrophil
low
level
consid
observ
elev
percentag
either
immunosuppress
immatur
neutrophil
popul
patient
day
fig
furthermor
lost
cell
surfac
neutrophil
treat
fmlf
pma
fig
compar
surfac
protein
express
marker
neutrophil
transmigr
hnerich
hnepoor
asn
shown
fig
increas
express
decreas
neutrophil
transmigr
bacteri
coinfect
patient
asn
versu
bacteri
coinfect
patient
asn
fig
complet
set
surfac
marker
assess
two
condit
comparison
blood
neutrophil
pretransmigr
neutrophil
transmigr
shown
fig
final
perform
bacteri
kill
assay
neutrophil
h
influenza
aureu
pardsassoci
gramneg
gramposit
bacteria
respect
neutrophil
transmigr
toward
bacteri
coinfect
asn
show
lower
abil
kill
h
influenza
aureu
transmigr
bacteri
coinfect
asn
fig
neutrophil
transmigr
toward
kill
h
influenza
similar
effici
transmigr
hnepoor
asn
aureu
less
effici
fig
blood
neutrophil
recruit
lung
children
risk
pard
due
lower
airway
viral
infect
gener
believ
rapidli
die
therein
lead
passiv
releas
hne
toxic
byproduct
promot
lung
contrast
convent
paradigm
find
present
support
notion
larg
popul
neutrophil
remain
viabl
undergo
profound
chang
upon
recruit
airway
patient
viabl
airway
neutrophil
demonstr
surfac
mobil
multipl
set
granul
lose
surfac
express
key
phagocyt
receptor
furthermor
airway
neutrophil
increas
express
hladr
typic
associ
profession
antigenpres
cell
thu
reflect
function
chang
investig
process
adapt
airway
inflamm
model
develop
group
studi
diseas
chronic
lung
inflamm
cf
asthma
copd
acut
lung
inflammatori
process
occur
children
acut
respiratori
failur
due
lower
airway
infect
model
allow
transepitheli
recruit
patholog
condit
neutrophil
cellfre
patient
airway
fluid
recapitul
cardin
featur
airway
neutrophil
collect
patient
vivo
addit
identifi
associ
activ
hne
exocytosi
bacteri
coinfect
within
hour
endotrach
intub
patient
observ
neutrophil
recruit
cellfre
airway
fluid
patient
coinfect
bacteria
becom
defici
respiratori
burst
capac
abil
kill
bacteria
hne
serin
proteas
contain
primari
granul
elev
level
bronchoalveolar
lavag
plasma
associ
sever
lung
injuri
extracellular
hne
reflect
live
neutrophil
activ
degranul
tracheal
aspir
necrot
neutrophil
releas
neutrophil
extracellular
trap
net
may
also
contribut
increas
extracellular
level
hne
thu
preclud
use
extracellular
hne
activ
stringent
marker
live
neutrophil
degranul
elev
level
lung
epitheli
line
fluid
patient
ard
also
associ
increas
sever
lung
primari
granul
exocytosi
airway
compar
blood
neutrophil
evidenc
increas
express
addit
decreas
express
latter
protein
contain
hne
mmp
cleavag
site
may
also
remov
membran
downregul
expect
express
gener
increas
upon
transmigr
due
degranul
secretori
vesicl
tertiari
howev
downregul
endocytos
cleav
high
activ
level
hne
secondari
granul
exocytosi
airway
neutrophil
evidenc
increas
express
compar
blood
neutrophil
whether
abnorm
activ
respons
leverag
therapeut
remain
unclear
inde
hne
inhibitor
sivelestat
fail
improv
mortal
ard
patient
like
due
compet
proteas
releas
damageassoci
molecular
pattern
molecul
alarmin
immunomodulatori
effect
neutrophil
tcell
airway
ard
signific
differ
neutrophil
activ
marker
blood
airway
compart
observ
patient
popul
consist
prior
result
highlight
import
studi
airway
fluid
cell
recruit
therein
rather
simpli
infer
airway
neutrophil
behavior
function
base
cell
isol
blood
neutrophil
prime
agent
gmcsf
tumor
necrosi
factor
lipopolysaccharid
delay
apoptosi
neutrophil
site
inflamm
increas
degranul
respiratori
burst
respons
activ
interestingli
one
role
assign
healthi
pulmonari
vasculatur
select
retain
prime
neutrophil
deprim
releas
deprim
mechan
may
dysfunct
ard
result
releas
prime
neutrophil
system
vasculatur
damag
extrapulmonari
migrat
healthi
donor
neutrophil
small
airway
epitheli
model
prime
neutrophil
undergo
respiratori
burst
howev
migrat
asn
high
ne
activ
attenu
respiratori
burst
upon
fmlf
stimul
decreas
respiratori
burst
presenc
hnerich
asn
bacteri
coinfect
patient
may
serv
rapidli
assess
biomark
bacteri
coinfect
mechan
explain
poor
kill
h
influenza
aureu
neutrophil
transmigr
hnerich
asn
model
associ
clinic
outcom
bacteri
coinfect
remain
explor
increas
rel
gene
transcript
level
shown
blood
neutrophil
ard
patient
rel
healthi
consist
find
upregul
surfac
express
neutrophil
transmigr
bacteri
coinfect
asn
influenc
immunoregulatori
pathway
axi
investig
possibl
mechan
explain
bacteri
coinfect
children
viral
induc
respiratori
failur
transepitheli
neutrophil
migrat
model
set
possibl
control
studi
fate
neutrophil
pard
patient
acknowledg
sever
limit
first
perform
full
function
analys
primari
airway
neutrophil
due
limit
cellular
materi
patient
instead
use
cell
surfac
marker
activ
proxi
inform
well
transepitheli
migrat
model
compar
chang
seen
blood
airway
neutrophil
patient
addit
experiment
data
come
transepitheli
migrat
model
recapitul
small
airway
respiratori
gener
tracheal
aspir
patient
actual
collect
airway
gener
howev
bronchoalveolar
lavag
children
commonli
perform
unless
need
diagnost
therapeut
purpos
sever
lung
injuri
second
limit
abil
collect
blood
sampl
children
weight
kg
without
central
venou
arteri
cathet
blood
sampl
made
pair
comparison
blood
airway
neutrophil
patient
imposs
nevertheless
despit
limit
number
patient
sampl
enough
patient
identifi
signific
differ
activ
immunomodulatori
marker
neutrophil
although
previous
show
differenti
neutrophil
behavior
compar
hyperton
salineinduc
sputum
cell
cf
patient
healthi
abl
includ
control
studi
owe
ethic
limit
obtain
nonclin
indic
airway
lavag
sampl
children
intub
elect
surgeri
addit
children
intub
airway
protect
rather
respiratori
failur
due
pulmonari
caus
neutrophilrich
airway
lavag
sampl
make
direct
comparison
cellular
materi
imposs
perform
instead
focus
serial
blood
airway
compart
sampl
time
picu
profil
neutrophil
chang
patient
may
act
control
futur
studi
children
studi
rang
age
day
year
major
year
age
limit
comparison
neutrophil
behavior
stratifi
age
final
patient
includ
studi
infect
varieti
respiratori
virus
due
limit
sampl
size
determin
effect
one
viru
airway
neutrophil
behavior
suscept
bacteri
coinfect
despit
infecti
heterogen
limit
number
sampl
abl
detect
signific
neutrophil
dysfunct
signal
presenc
activ
neutrophil
environ
summari
studi
highlight
phenotyp
differ
airway
blood
neutrophil
patient
risk
pard
due
lower
respiratori
tract
viral
infect
without
bacteri
coinfect
emphas
need
studi
compartmentspecif
behavior
neutrophil
addit
show
bacteri
coinfect
day
ill
may
predict
use
marker
neutrophil
granul
releas
immunomodulatori
protein
metabol
activ
may
inform
antimicrobi
treatment
patient
final
showcas
novel
vitro
transmigr
model
studi
airway
neutrophil
function
follow
recruit
condit
patient
cellfre
airway
fluid
lay
critic
foundat
futur
mechanist
therapeut
studi
airway
neutrophil
pard
